Fos expression in the trigeminocervical complex of the cat after stimulation of the superior sagittal sinus is reduced by L-NAME

Neuroscience Letters

Volumn 266, Issue 3, 1999, Pages 173-176

  Hoskin, Karen L ^a   Bulmer, David C E ^a   Goadsby, Peter J ^a  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

Headache; Migraine; Nitric oxide; Trigeminal nucleus

Indexed keywords

N(G) METHYLARGININE; ONCOPROTEIN;

ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ARTICLE; CAT; ELECTROSTIMULATION; HEADACHE; MIGRAINE; NOCICEPTIVE STIMULATION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SUPERIOR SAGITTAL SINUS; TRIGEMINAL NUCLEUS;

ANIMALS; CATS; CRANIAL SINUSES; ELECTRIC STIMULATION; ENZYME INHIBITORS; NECK; NEURONS; NG-NITROARGININE METHYL ESTER; PROTO-ONCOGENE PROTEINS C-FOS; SPINAL CORD; TRIGEMINAL NUCLEI;

EID: 0033553593     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(99)00281-5     Document Type: Article

References (29)

1. Bereiter D.A. Morphine and somatostatin analogue reduce c-FOS expression in trigeminal subnucleus caudalis produced by corneal stimulation in the rat. Neuroscience. 77:1997;863-874.
2. Berman A.L. The Brain Stem of the Cat: A Cytoarchitectonic Atlas with Stereotaxic Co-ordinates. 1968;University of Wisconsin Press, Madison.
3. Bulmer D.C.E., Hoskin K.L., Lasalandra M., Goadsby P.J. L-NAME reduces Fos expression in trigemino-cervical complex after superior saggitta1 sinus stimulation. Br. J. Pharmacol. 125:1998;49P.
4. Cumberbatch M.J., Hill R.G., Hargreaves R.J. Rizatnptan has central antinociceptive effects against durally evoked responses. Eur. J. Pharmacol. 328:1997;37-40.
5. Davis K.D., Dostrovsky J.O. Activation of trigeminal brainsiem nociceptive neurons by dural artery stimulation. Pain. 25:1986;395-401.
6. Goadsby P.J. Bench to bedside: what have we learnt recently abotic headache? Curr. Opin. Neurol. 10:1997;215-222.
7. Goadsby P.J. A Triptan too far. J. Neurol. Neurosurg. Psychiatry. 64:1998;143-147.
8. Goadsby P.J., Hoskin K.L. The distribution of trigeminovascular afferents in the non-human primate brain macca nemestrina immunocytochemical study. J. Anat. 190:1997;367-375.
9. Goadsby P.J., Hoskin K.L. Inhibition of trigeminal neurons by intravenous administration of the serotonin (5HT)-1-D receptor agonist zolmitriptan (311C90): are brain stem sites a therapeutic target in migraine? Pain. 67:1996;355-359.
10. Goadsby P.J., Knight Y.E. Naratriptan inhibits trigeminal neurons after intravenous administration through an action at the serotonin (5HT1B/1D ) receptors. Br. J. Pharmacol. 122:1997;918-922.
11. Hammond D.L., Presley R., Gogas K.R., Bausbaum A.I. Morphine suppresses Fos protein-like immunoreactivity in the spinal cord and nucleus tractus solitani evoked by a noxious visceral stimulus in the rat. J. Comp. Neurol. 315:1992;244-253.
12. Hoskin K.L., Goadsby P.J. Exposure and isolation of the superior sagittal sinus elicits Fos in the trigeminal nucleus caudalis and dorsal horn of the cervical spinal cord: how long should you wait? Brain Res. 1999;. in press.
13. Hoskin K.L., Kaube H., Goadsby P.J. Central activation of the trigeminovascular pathway in the cat is inhibited by dihydroergotamine: a cFos and electrophysiology study. Brain. 119:1996;249-256.
14. Hoskin K.L., Kaube H., Goadsby P.J. Sumatriptan can inhibit trigeminal afferents by an exclusively neural mechanism. Brain. 119:1996;1419-1428.
15. Hu J.W., Dostrovosky J.O., Sessle B.J. Functional properties of neurons in the cat trigeminal subnucleus caudalis (medullary dorsal horn). 1. Response to pro-facial noxious and nonnoxious stimuli and projections to thalamus and subnucleus oralis. J. Neurophysiol. 45:1981;173-191.
16. Hunt S.P., Pini A., Evan G. Induction of c-fos like protein in spinal cord neurons following sensory stimulation. Nature. 328:1987;1686-1704.
17. Kaube H., Hoskin K.L., Goadsby P.J. Intravenous acetylsalicylic acid inhibits central trigeminal neurons in the dorsal horn of the upper cervical spinal cord in the cat. Headache. 33:1993;541-550.
18. Kaube H., Hoskin K.L., Goadsby P.J. Sumatriptan inhibits central trigeminal neurons only after blood-brain barrier disruption. Br. J. Pharmacol. 109:1993;788-792.
19. Kaube H., Keay K., Hoskin K.L., Bandler K., Goadsby P.J. Expression of c-fos-like immunoreactivity in the trigeminal nucleus caudalis and high cervical cord following stimulation of the sagittal sinus in the cat. Brain Res. 629:1993;95-102.
20. Lance J.W., Goadsby P.J. Mechanism and Management of Headache. 6th edn. 1998;Butterworth-Heinemann, Oxford.
21. Lassen L.H., Ashina M., Christiansen I., Ulrich V., Olesen J. Nitric oxide synthesis inhibition in migraine. Lancet. 349:1997;401-402.
22. Mitsikostas D.D., Sanchez del Rio M., Waeber C., Moskowitz M.A., Cutrer F.M. The NMDA receptor antagonist MK-801 reduces capsaicin-induced c-fos expression within rat trigeminal nucleus caudafis. Pain. 76:1998;239-248.
23. Moncada S., Palmer R.M.J., Higgs E.A. Nitric oxide: physiology. pathophysiology, and pharmacology. Pharmacol. Rev. 43:1991;109-142.
24. Ray B.S., Wolff H.G. Experimental studies on headache. Pain sensitive structures of the head and their significance in headache. Arch. Surg. 41:1940;813-856.
25. Rexed B. A cytoarchitectonic atlas of the spinal cord in the cat. J. Comp. Neurol. 96:1954;297-380.
26. Shepheard S.L., Williamson D.J., Williams J., Hill R.G., Hargreaves R.J. Comparison of the effects of sumatriptan and the NK 1 antagonist CP on plasma extravasation in the dura mater and c-fos mRNA expression in the trigeminal nucleus caudalis of rats. Neuropharmacology. 34:1995;255-261.
27. Siegel S. Non-parametric Statistics for the Behavioural Sciences. 1956;McCraw-Hill, New York.
28. Storer R.J., Butler P., Hoskin K.L., Goadsby P.J. A simple method, using 2-hydroxypropyl-β-cyclodextnn, of administering α-chloralose at room temperature. J. Neurosci. Meth. 77:1997;49-53.
29. Storer R.J., Goadsby P.J. Trigeminovascular nociceptive transmission involves NMDA and non-NMDA glutamate receptors. Neuroscience. 90:1999;1371-1376.